| Literature DB >> 35625543 |
Albert C Dos Santos1, Mateus L Nogueira2, Felipe P de Oliveira2, Emmanoel V Costa1, Daniel P Bezerra2.
Abstract
Duguetia A. St. Hill (Annonaceae) is recognized as one of the major genera with approximately 100 species, 67 of which are found in Brazil (29 of those are endemic). They are arboreal species with edible fruits known as "pindaíba", "pindaíva" "pinha", and "envira" in Brazil. Many Duguetia species, in particular, have been used in traditional medicine to treat renal colic, stomachache, rheumatism, cough, toothache, muscle pain, fever, gastrointestinal pain, and breathing difficulties. In this study, we reviewed the chemical constituents and pharmacological properties of essential oils (EOs) from Duguetia species. A total of 12 species were found, along with their EO chemical constituents and bioactivities. Bicyclogermacrene, humulene epoxide II, spathulenol, germacrene D, caryophyllene oxide, viridiflorene, α-pinene, β-caryophyllene, and β-pinene were the main chemical constituents reported. The pharmacological effects of Duguetia species EOs included anti-inflammatory, antinociceptive, antibacterial, antifungal, antioxidant, anti-trypanosoma, cytotoxic and antitumor properties. This information adds to our understanding of the potential of the EOs of Duguetia species.Entities:
Keywords: Duguetia; chemical composition; essential oil; pharmacological activity
Mesh:
Substances:
Year: 2022 PMID: 35625543 PMCID: PMC9138787 DOI: 10.3390/biom12050615
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Medicinal uses of Duguetia species.
| Species | Popular Name in Brazil | Part Used | Popular Uses | References |
|---|---|---|---|---|
|
| Pindaíba-da-mata | Leaves; branch | Inflammatory diseases; | [ |
|
| Pinha do campo | Leaves | Renal colic | [ |
| Root | Stomachache | [ | ||
| Rheumatism | [ | |||
| Seeds | Against lice | [ | ||
|
| Caniceiro preto | - | Rheumatism | [ |
|
| Unknown | - | Cough; Toothache | [ |
|
| Unknown | Bark | Gastrointestinal pain; | [ |
|
| Envira preta | Bark | Muscle pain | [ |
| Cough | ||||
| Leaves | Fever | |||
| Cold sweat |
Main chemical constituents of Duguetia species EOs.
| Species | Part Used | Total Components | Major Constituents 1 | References |
|---|---|---|---|---|
| Flowers | 9 (69.3%) | Limonene (14.1%), | [ | |
| Leaves and stem | 76 (4) | α-Eudesmol (80.3%) and spathulenol (5.0%) | [ | |
| Bark | 76 (4) | Germacrene D (16.5%), cyperene (10.6%), α-muurolol (8.6%), humulene epoxide II (5.3%), spathulenol (5.0%), caryophyllene oxide (5.0%), δ-cadinene (4.3%), α-muurolene (4.2%), and β-elemene (4.0%) | [ | |
| Stem | 3 (4) | Germacrene D (16.5%), cyperene (10.6%) and α-muurolol (8.6%) | [ | |
| Leaves and Stem | 76 (4) | Spathulenol (58.7%), α-muurolol (6.2%) and humulene epoxide II (4.3%) | [ | |
| Branches | 2 (4) | Spathulenol (58.7%), and α-muurolol (6.2%) | [ | |
| Stem | 19 (4) | 2,4,5-Trimethoxystyrene (29.2%), α-asarone (23.8%), bicyclogermacrene (8.6%), | [ | |
| 39 (4) | α-Gurjunene (22.2%), 2,4,5-trimethoxystyrene (19.7%), cyperene (16.0%), α-asarone (10.1%), and | [ | ||
| 24 (4) | ( | [ | ||
| 8 (4) | α-Asarone (36.4%), 2,4,5-trimethoxystyrene (27.8%), bicyclogermacrene (11.1%), α-gurjunene (10.5%), and cyperene (5.8%) | [ | ||
| Leaves 2 | 17 (99.4%) | β-Phellandrene (42.2%), bicyclogermacrene (20.7%), myrcene (6.8%), spathulenol (5.5%), α-phellandrene (4.6%), and sabinene (4.3%) | [ | |
| 17 (99.7%) | Sabinene (25.1%), terpinen-4-ol (16.2%), | |||
| 18 (99.2%) | Bicyclogermacrene (29.1%), spathulenol (18.3%), germacrene D (9.6%), | |||
| 18 (100%) | Bicyclogermacrene (24%), germacrene D (15%), trans-caryophyllene (12.9%), spathulenol (12.4%), and caryophyllene oxide (6.8%) | |||
| 19 (100%) | Bicyclogermacrene (21.4%), germacrene D (13.6%), spathulenol (12.2%), and caryophyllene oxide (5.2%) | |||
| 20 (99.7%) | Terpinen-4-ol (21.6%), spathulenol (20.9%), sabinene (17.3%), and p-cymene (5.6%) | |||
| 31 (4) | Spathulenol (17.8%), bicyclogermacrene (16.2%), germacrene D (13.0%), β-caryophyllene (11.5%), and viridiflorol (4.0%) | [ | ||
| Leaves | 33 (91.4%) | Germacrene D (28.1%), viridiflorene (24.0%), β-pinene (12.6%), α-pinene (9.1%), and β-caryophyllene (5.6%) | [ | |
| 4 (96%) | β-Bisabolene (81.0%), elemicin (8.0%), and germacrene D (4.2%) | [ | ||
| Leaves | 18 (4) | [ | ||
| Leaves | 24 (4) | |||
| Bark 3 | 72 (99.6%) | β-Elemene (12.7%), caryophyllene oxide (12.4%), β-selinene (8.4%), humulene epoxide II (7.4%), and β-eudesmol (6.8%) | [ | |
| 51 (99.3%) | β-elemene (14.9%), caryophyllene oxide (10.7%) β-selinene (10.4%), β-eudesmol (7.9%), humulene epoxide II (6.8%), β-sinensal (5.4%), and khusinol (5.0%) | |||
| Leaves | 5 (4) | β-Bisabolene (56.2%), 2,4,5-trimethoxystyrene (19.1%), | [ | |
| Branches | 37 (92.9%) | β-Elemene (8.3%), caryophyllene oxide (7.7%), β-eudesmol (7.2%), β-selinene (7.1%), β-caryophyllene (6.2%), δ-cadinene (5.5%), cadina-1,4-dien-3-ol (5.2%), cadalene (4.8%), and δ-elemene (4.1%) | [ | |
| Leaves | 33 (95.5%) | Germacrene D (44.3%), α-pinene (13.0%), viridiflorene (9.3%), β-pinene (9.2%), and β-caryophyllene (6.8%) | [ | |
| Leaves and stem | 76 (4) | Spathulenol (52.2%), | [ | |
| Aerial parts | 20 (97.3%) | 4-Heptanol (33.8%), α-thujene (18.4%), ( | [ | |
| Leaves and stem | 76 (4) | Spathulenol (46.5%), caryophyllene oxide (28.9%), and α-pinene (6.1%) | [ | |
| Leaves and stem | 76 (4) | α-Pinene (21.1%), bicyclogermacrene (17.6%), bulnesol (10.6%), spathulenol (10.5%), guaiol (8.1%), globulol (5.7%), humulene epoxide II (5.0%), and β-pinene (4.2%) | [ | |
| Bark | 76 (4) | β-Phellandrene (45.7%), guaiol (8.3%), α-cadinol (7.4%), ( |
1 Only compounds with percentage concentrations greater than or equal to 4% are displayed. 2 The chemical compositions of the leaves vary due to the intensity of the odor and the location from which they were collected. 3 The extraction times for EO obtention (2 h and 4 h) resulted in different chemical compositions. 4 Percentage not described by the authors in relation to the total composition of the essential oil.
Figure 1Chemical structures of the main constituents of the essential oils of Duguetia species.
Pharmacological properties of Duguetia species EOs.
| Pharmacological Effects | Part Used | Actions | References |
|---|---|---|---|
|
| |||
|
| Stem | After 6 h, EO inhibited paw edema induced by LPS by 92.4%. | [ |
| Stem | After 2 h of LPS injection, doses of 3 and 10 mg/kg of EO inhibited paw edema by 90.9% and 92.42%, respectively. After 4 h, there was a significant reduction effect, with percentages of 77.8% (3 mg/kg) and 81.5% (10 mg/kg). | [ | |
|
| Bark | EO at doses of 50, 100 and 200 mg/kg significantly reduced paw edema caused by carrageenan in 20.8%, 36.5% and 49.0%, respectively. | [ |
| Branches | After 4 h, EO reduced the formation of paw edema caused by carrageenan by 18.3% (50 mg/kg), 32.3% (100 mg/kg) and 44.1% (200 mg/kg). | [ | |
|
| |||
|
| Stem | EO inhibited formalin-induced activity, and caffeine (10 mg/kg) and naloxone (5 mg/kg) administration reversed the EO’s antinociceptive activity. | [ |
| Stem | Inhibition of 43.4% and 44.1% of formalin-induced activity was observed during the 1st phase at doses of 10 and 30 mg/kg, respectively. In the 2nd phase, there was also reduction in licking time at doses of 10 mg/kg (30.9%) and 30 mg/kg (39.8%). | [ | |
|
| Bark | Number of abdominal contractions (ED50 = 21.8 mg/kg) and paw-licking time 1st phase (ED50 = 5.3 mg/kg) and 2nd phase (ED50 = 1.4 mg/kg) were reduced in the formalin test. | [ |
| Branches | In the formalin test, EO caused significant and time-dependent inhibition of paw licking at doses of 50, 100 and 200 mg/kg at 1st and 2nd phases. | [ | |
|
| |||
|
| Leaves | EO showed weak activity against | [ |
|
| Bark | EO inhibited the growth of | [ |
|
| Leaves | EO was active against | [ |
|
| Aerial parts | EO was active for Gram-positive microorganisms | [ |
|
| |||
|
| Aerial parts | EO showed trypanocidal activity against the amastigote and trypomastigote forms of | [ |
|
| |||
|
| Branches | EO presented antioxidant effect, demonstrated through the DPPH radical, potency reduction and β-carotene assays. It inhibited lipid peroxidation by 41.5% (EC50 equal to 159.4 µg/mL). | [ |
|
| |||
|
| Stem | EO was active against | [ |
| Stem | EO was active against | [ | |
|
| Bark | EO was cytotoxic against | [ |
|
| Leaves | EO exhibited cytotoxicity towards tumor cell lines and showed IC50 value of 11.6 µg/mL for human larynx carcinoma (Hep2) cell line. | [ |
| Leaves | EO was toxic to | [ | |
|
| Leaves | EO exhibited cytotoxic effect with IC50 values of 16.9, 19.2, 13.1 and 19.3 µg/mL against B16-F10, HepG2, HL-60 and K562 cell lines, respectively. In the in vivo experiment, tumor growth was reduced by 5.4 and 37.5% at doses of 40 and 80 mg/kg, respectively. | [ |
Figure 2Main chemical composition and pharmacological properties of Duguetia species.